These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 8239560)

  • 1. Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis.
    Katz D; Taubenberger JK; Cannella B; McFarlin DE; Raine CS; McFarland HF
    Ann Neurol; 1993 Nov; 34(5):661-9. PubMed ID: 8239560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical usefulness of MRI in acute phase of spinal multiple sclerosis--influence of high-dose steroid therapy in acute phase].
    Nomura M; Suzumura A; Anno H; Miyata E; Koga S; Yamamoto H
    Rinsho Shinkeigaku; 1995 Mar; 35(3):225-30. PubMed ID: 7614741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentetate dimeglumine-enhancing magnetic resonance imaging lesions.
    Smith ME; Stone LA; Albert PS; Frank JA; Martin R; Armstrong M; Maloni H; McFarlin DE; McFarland HF
    Ann Neurol; 1993 May; 33(5):480-9. PubMed ID: 8498825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple sclerosis disease activity correlates with gadolinium-enhanced magnetic resonance imaging.
    Gonzalez-Scarano F; Grossman RI; Galetta S; Atlas SW; Silberberg DH
    Ann Neurol; 1987 Mar; 21(3):300-6. PubMed ID: 3606036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance imaging in multiple sclerosis: an overview.
    Colosimo M; Amatruda A; Cioffi RP
    Ital J Neurol Sci; 1992 Dec; 13(9 Suppl 14):113-23. PubMed ID: 1345732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gadofluorine M enhancement allows more sensitive detection of inflammatory CNS lesions than T2-w imaging: a quantitative MRI study.
    Bendszus M; Ladewig G; Jestaedt L; Misselwitz B; Solymosi L; Toyka K; Stoll G
    Brain; 2008 Sep; 131(Pt 9):2341-52. PubMed ID: 18669504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of magnetic resonance imaging in the diagnosis and prognosis of multiple sclerosis].
    Zivadinov R; Sepcić J
    Lijec Vjesn; 2006; 128(9-10):295-308. PubMed ID: 17128669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Major differences in the dynamics of primary and secondary progressive multiple sclerosis.
    Thompson AJ; Kermode AG; Wicks D; MacManus DG; Kendall BE; Kingsley DP; McDonald WI
    Ann Neurol; 1991 Jan; 29(1):53-62. PubMed ID: 1996879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MR imaging of primary intracranial malignant lymphoma.
    Ueda F; Takashima T; Suzuki M; Kadoya M; Yamashita J; Kida T
    Radiat Med; 1995; 13(2):51-7. PubMed ID: 7667507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serial magnetic resonance imaging of acute disseminated encephalomyelitis, including evaluation of the contrast-enhancing effect of lesions by Gd-DTPA].
    Tanaka Y; Matsuo M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1996 Jan; 56(1):25-31. PubMed ID: 8857095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimizing brain MRI protocols in the follow-up of patients with multiple sclerosis T2-weighted MRI of the brain after the administration of gadopentetate dimeglumine.
    Taschner CA; Kirsch EC; Scheffler K; Wetzel SG; Schulte-Mönting J; Kappos L; Radü EW
    Magn Reson Imaging; 2005 Apr; 23(3):469-74. PubMed ID: 15862648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurosarcoidosis: gadolinium-enhanced MR imaging.
    Williams DW; Elster AD; Kramer SI
    J Comput Assist Tomogr; 1990; 14(5):704-7. PubMed ID: 2398145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Magnetic resonance tomography with gadolinium DTPA in multiple sclerosis. Findings in initial manifestation and later disease stages].
    Rüttinger H; Hermes M
    Nervenarzt; 1990 Jun; 61(6):356-60. PubMed ID: 2377261
    [No Abstract]   [Full Text] [Related]  

  • 14. [Magnetic resonance imaging of disseminated sclerosis].
    Christiansen AP; Wanscher B; Larsson HB; Henriksen O
    Ugeskr Laeger; 1994 Oct; 156(43):6348-52. PubMed ID: 7810007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Magnetic resonance imaging in multiple sclerosis].
    Tourbah A; Berry I
    Pathol Biol (Paris); 2000 Mar; 48(2):151-61. PubMed ID: 10815291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early contrast-enhanced magnetic resonance imaging with fluid-attenuated inversion recovery in multiple sclerosis.
    Kataoka H; Taoka T; Ueno S
    J Neuroimaging; 2009 Jul; 19(3):246-9. PubMed ID: 19021828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The contrast enhancement of brain and spinal cord tumors using Gd-DTPA in magnetic resonance tomography with an extra-low magnetic-field intensity].
    Kornienko VN; Pronin IN; Turkin AM; Fadeeva LM
    Zh Vopr Neirokhir Im N N Burdenko; 1993; (4):13-7. PubMed ID: 8296501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spatial diversity of blood-brain barrier alteration and macrophage invasion in experimental autoimmune encephalomyelitis: a comparative MRI study.
    Ladewig G; Jestaedt L; Misselwitz B; Solymosi L; Toyka K; Bendszus M; Stoll G
    Exp Neurol; 2009 Nov; 220(1):207-11. PubMed ID: 19733560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance imaging of thymic epithelial tumors.
    Kushihashi T; Fujisawa H; Munechika H
    Crit Rev Diagn Imaging; 1996 Aug; 37(3):191-259. PubMed ID: 8872410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study of spondylodiscitis with magnetic resonance. Use of gadolinium-DTPA].
    Duca S; Lo Bello G; Bianchi G; Di Paola A
    Radiol Med; 1993 Nov; 86(5):587-94. PubMed ID: 8272542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.